Risk factors of central lymph node metastasis in cN0 papillary thyroid carcinoma: A study of 529 patients

Medical Science Monitor

Volumn 20, Issue , 2014, Pages 807-811

  Liang, Keke ^a   He, Liang ^a   Dong, Wenwu ^a   Zhang, Hao ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

CLND; CLNM; CN0; Lymph nodes; Prophylactic; Risk factors; Thyroid neoplasms

Indexed keywords

THYROTROPIN;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CENTRAL LYMPH NODE METASTASIS; CLINICALLY LYMPH NODE NEGATIVE PAPILLARY THYROID CARCINOMA; ECTOPIC THYROID GLAND; FEMALE; GENDER; HASHIMOTO DISEASE; HUMAN; ISTHMUSECTOMY; LOBECTOMY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; MULTIVARIATE ANALYSIS; PATHOLOGY; RISK FACTOR; SOLITARY FIBROUS TUMOR; THYROID CARCINOMA; THYROID SURGERY; THYROID TUMOR; THYROIDECTOMY; TUMOR VOLUME; UNIVARIATE ANALYSIS; CARCINOMA; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CARCINOMA; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; THYROID NEOPLASMS; YOUNG ADULT;

EID: 84900862285     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.890182     Document Type: Article

References (22)

1. Lundgren CI, Hall P, Dickman PW, Zedenius J: Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer, 2006; 106: 524-31
2. Wang Q, Chu B, Zhu J et al: Clinical analysis of prophylactic central neck dissection for papillary thyroid carcinoma. Clin Transl Oncol, 2013; 1-5
3. Rotstein L: The role of lymphadenectomy in the management of papillary carcinoma of the thyroid. J Surg Oncol, 2009; 99: 186-88
4. Robbins KT, Shaha AR, Medina JE et al: Consensus statement on the classifi{ligature}cation and terminology of neck dissection. Arch Otolaryngol Head Neck Surg, 2008; 134: 536-38
5. Roh JL, Kim JM, Park CI: Central compartment reoperation for recurrent/ persistent differentiated thyroid cancer: patterns of recurrence, morbidity, and prediction of postoperative hypocalcemia. Ann Surg Oncol, 2011; 18: 1312-18
6. Roh JL, Kim JM, Park CI: Central lymph node metastasis of unilateral papillary thyroid carcinoma: patterns and factors predictive of nodal metastasis, morbidity, and recurrence. Ann Surg Oncol, 2011; 18: 2245-50
7. Anil S, Radu B, Ricardo L: Metastatic papillary thyroid carcinoma with absence of tumor focus in thyroid gland. Am J Case Rep, 2013; 14: 73-75
8. Koo BS, Choi EC, Yoon YH et al: Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma. Ann Surg, 2009; 249: 840-44
9. NCCN Clinical Practice Guidelines in Oncology. Thyroid carcinoma,Version 2, 2012
10. Kim BY, Jung CH, Kim JW et al: Impact of cilinicopathologic factors on subclinical central lymph node metastasis in papillary thyroid microcarcinoma. Yonsei Med J, 2012; 53: 924-30
11. Mulla M, Schulte KM: Central cervical lymph node metastases in papillary thyroid cancer: a systematic review of imaging-guided and prophylactic removal of the central compartment. Clin Endocrinol (Oxf), 2012; 76: 131-36
12. Costa S, Giugliano G, Santoro L et al: Role of prophylactic central neck dissection in cN0 papillary thyroid cancer. Acta Otorhinolaryngologica Ital, 2009; 29, 61-69
13. Carling T, Long WD, Udelsman R: Controversy surrounding the role for routine central lymph node dissection for differentiated thyroid cancer. Curr Opin Oncol, 2012; 22: 30-34
14. Ito Y, Tomoda C, Uruno T et al: Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg, 2006; 30: 91-99
15. Ahn JH, Lee JH, Yi JS et al: Diagnostic accuracy of CT and ultrasonography for evaluating metastatic cervical lymph nodes in patients with thyroid cancer. World J Surg, 2008; 32: 1552-58
16. Kouvaraki MA, Shapiro SE, Fornage BD et al: Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery, 2003; 134: 946-54
17. Ito Y, Fukushima M, Higashiyama T et al: Tumor size is the strongest predictor of microscopic lymph node metastasis and lymph node recurrence of N0 papillary thyroid carcinoma. Endocr J, 2013; 60: 113-17
18. Bozec A, Dassonville O, Chamorey E et al: Clinical impact of cervical lymph node involvement and central neck dissection in patients with papillary thyroid carcinoma: a retrospective analysis of 368 cases. Eur Arch Otorhinolaryngol, 2011; 268: 1205-12
19. Choi YJ, Yun JS, Kook SH et al: Clinical and Imaging Assessment of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinomas. World J Surg, 2012; 34: 1494-99
20. Zhang L, Wei WJ, Ji QH et al: Risk Factors for Neck Nodal Metastasis in Papillary Thyroid Microcarcinoma: A Study of 1066 Patients. J Clin Endocrinol Metab, 2012; 97: 1250-57
21. Wang W, Gu J, Shang J, Wang K: Correlation analysis on central lymph node metastasis in 276 patients with cN0 papillary thyroid carcinoma. Int J Clin Exp Pathol, 2013; 6: 510-15
22. Kim SS, Lee BJ, Lee JC et al: Coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma: The influence of lymph node metastasis. Head Neck, 2011; 33: 1272-77